Pharmafile Logo
Pharmafocus logo
Advanced Search

UK biotech body elects new chairman

September 3, 2010
Research and Development BIA, appointment, research and development

Cellzome’s president and chief executive Tim Edwards has been elected chairman of the BioIndustry Association. Commenting on his election he …

Appointment

Contract research news in brief

September 3, 2010
Research and Development Cyprotex, Epistem, INC Research, Jubilant, Laxal Pharma

A round-up of recent news from the CRO sector, featuring updates from Cyprotex, INC Research, Laxai Pharma, Asuragen, Jubilant Organosys …

News
Nigel Brooksby

Nigel Brooksby joins Prism Ideas

September 2, 2010
Medical Communications, Research and Development Prism Ideas, appointment, medical communications, research and development

Former Sanofi-Aventis UK chairman and managing director Nigel Brooksby has joined Cheshire, UK-based Prism Ideas as non-executive chairman. The medical …

Appointment
Abbott Park

Abbott’s Meridia ‘increases heart attack risk’

September 2, 2010
Sales and Marketing Abbott, Meridia, drug safety

Abbott’s weight-loss drug Meridia increases the risk of stroke and heart attack in patients with heart disease, according a study …

News

Genzyme available for ‘fair value’, says Termeer

September 2, 2010
Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Genzyme’s chief executive Henri Termeer has said his company could be for sale to Sanofi-Aventis if it offers a ‘fair …

News

Pfizer acquires ‘protein misfolding’ specialist

September 2, 2010
Research and Development FoldRx, Pfizer, cystic fibrosis

Pfizer has bolstered its presence in rare and orphan diseases with the acquisition of FoldRx, a US drug discovery firm …

News

Cephalon chairman takes leave of absence

September 2, 2010
Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect. The company …

Appointment

CME Spotlight: Reshaping the healthcare conversation

September 2, 2010
Medical Communications CME Spotlight

In a recent conversation with the head of an international group of medical agencies, I was somewhat surprised to hear …

Feature
Bayer's Questival site

Digital Pharma: Augmented reality gateway for Bayer haemophilia site

September 1, 2010
Medical Communications Digital Pharma blog, augmented reality, disease awareness campaigns, haemophilia

Bayer Healthcare has launched a new disease awareness campaign that uses augmented reality techniques to engage with its target audience. …

News

Lung cancer vaccine poised to begin phase IIb/III trials

September 1, 2010
Research and Development NSCLC, TG4010, Transgene, cancer vaccine

French biotech firm Transgene has received positive scientific advice from the EMA for late stage trials of its new lung …

News

Eye treatment could be commercial breakthrough for ThromboGenics

September 1, 2010
Research and Development ThromboGenics, eye care, microplasmin

Belgian biopharma company ThromboGenics could have a major product on its hands in the shape of new eye treatment. The …

News
Pandemrix pack

EMA to assess GSK flu vaccine for narcolepsy link

September 1, 2010
Research and Development, Sales and Marketing GlaxoSmithKline, Pandemrix, h1n1

The European Medicines Agency has launched a review of GlaxoSmithKline’s influenza vaccine Pandemrix. The European Commission asked the EMA to …

News

Pharma and the iPhone: there’s an app for that

September 1, 2010
Medical Communications, Research and Development, Sales and Marketing ipad, iphone

The iPhone and its new, larger cousin the iPad, have captured the hearts of many technology lovers, and have ushered …

Feature

Kendle appoints Mark Roseman chief marketing officer

September 1, 2010
Research and Development Kendle, appointment, research and development

Mark Roseman has joined clinical research organisation Kendle as senior vice president and chief marketing officer. He has more than …

Appointment

Talking R&D: Strategic vs full service CRO

September 1, 2010
Research and Development CRO, Talking Point, Talking R&D

CRF Health’s Greg Jewett and Medpace’s Alita Hassan debate the merits of a strategic or a full service contract research …

Feature
Roche building

Roche coy on job cut reports

September 1, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Roche, job cuts

Roche is reportedly set to cut thousands of pharma jobs to reduce costs and boost profitability following a series of …

News

Paul Phull joins PharmaVentures

August 31, 2010
Sales and Marketing PharmaVentures, appointment, sales and marketing

Oxford, UK-based PharmaVentures has appointed Paul Phull as a senior director to its corporate advisory business. He joins the company …

Appointment

Swiss approval for Novartis’ Tasigna

August 31, 2010
Sales and Marketing Novartis, Tasigna, Tekamlo

Novartis’ Tasigna has received its first European approval as a first-line treatment after Swiss authorities green-lighted the blood cancer drug …

News

Sanofi’s $18.5bn bid for Genzyme rejected

August 31, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi-Aventis

Sanofi-Aventis has gone public with its $18.5 billion offer for Genzyme after the US biotech’s board unanimously rejected the bid …

News

Lonza buys Vivante to get bigger in biologics

August 31, 2010
Manufacturing and Production Lonza, Vivante

Swiss contract manufacturer and fine chemicals firm Lonza has expanded its biologics production capacity with the purchase of US firm …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026